CT LUCIA 602
CT LUCIA 602
Price as per contract
ZEISS aspheric 3-piece IOLs
Reliable monofocal hydrophobic IOL performance
Designed to ensure IOL stability in the capsular bag
High corrected visual acuity1
Good refractive results2
Low inflammatory reaction1
Reliable monofocal hydrophobic IOL performance
Designed to ensure IOL stability in the capsular bag
High corrected visual acuity1
Good refractive results2
Low inflammatory reaction1
Description
ZEISS 3-piece IOLs are available in a spheric and an aspheric (CT LUCIA 602) version. Both featuring highly stable PVDF haptics, designed to ensure IOL stability in the capsular bag. CT LUCIA® 3-piece IOLs from ZEISS are glistening-free1,2, and have a 360° square edge design for a low PCO rate.3
ZEISS 3-piece IOLs are designed for cases when IOL stability in the capsular bag is challenging. Providing consistently high corrected visual acuity1, achieving good and precise refractive results2, ensuring low rate of early post-operative Nd:YAG capsulotomies2 and enabling low inflammatory reaction.1
High corrected visual acuity1
The high stability of the lens in the capsular bag together with its good positioning behaviour supporting good visual outcome after surgery.
Good refractive results2
The reliable performance of the lens after surgery when it comes to IOL stability in the capsular bag as well as low amount of post-surgery complications ensuring good refractive results of the lens.
Low inflammatory reaction1
The safety of the lens after implantation proved to be very re-ensuring with low rates of post- surgery events. Inflammatory reaction were minimal and mostly related to the procedure itself and not to the IOL.
1 EC-3 Pivotal Clinical Study (FDA IDE study) , n=324, 12 month.
2 European EC-3 Clinical Investigation, n=96, 6 month, South American EC-3 Clinical Investigation.
3 Borkenstein & Borkenstein (2018) Clinical Ophthalmology 2018:12 1219–1227.
CAP-en-US_32_174_0327I
ZEISS 3-piece IOLs are designed for cases when IOL stability in the capsular bag is challenging. Providing consistently high corrected visual acuity1, achieving good and precise refractive results2, ensuring low rate of early post-operative Nd:YAG capsulotomies2 and enabling low inflammatory reaction.1
High corrected visual acuity1
The high stability of the lens in the capsular bag together with its good positioning behaviour supporting good visual outcome after surgery.
Good refractive results2
The reliable performance of the lens after surgery when it comes to IOL stability in the capsular bag as well as low amount of post-surgery complications ensuring good refractive results of the lens.
Low inflammatory reaction1
The safety of the lens after implantation proved to be very re-ensuring with low rates of post- surgery events. Inflammatory reaction were minimal and mostly related to the procedure itself and not to the IOL.
1 EC-3 Pivotal Clinical Study (FDA IDE study) , n=324, 12 month.
2 European EC-3 Clinical Investigation, n=96, 6 month, South American EC-3 Clinical Investigation.
3 Borkenstein & Borkenstein (2018) Clinical Ophthalmology 2018:12 1219–1227.
CAP-en-US_32_174_0327I
